Phase I study of docetaxel plus S-1 combination chemotherapy for recurrent non-small cell lung cancer

S-1 is a novel oral fluorouracil prodrug that plays a role in non-small cell lung cancer (NSCLC). Docetaxel (DTX) is one of the standard agents for relapsed NSCLC. We performed a phase I study of DTX plus S-1 combination therapy as second-line treatment for NSCLC to determine the maximum tolerated d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: FUJITAKA, KAZUNORI, HATTORI, NOBORU, SENOO, TADASHI, IWAMOTO, HIROSHI, OHSHIMO, SHINICHIRO, KANEHARA, MASASHI, ISHIKAWA, NOBUHISA, HARUTA, YOSHINORI, MURAI, HIROSHI, KOHNO, NOBUOKI
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2011
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3412446/
https://ncbi.nlm.nih.gov/pubmed/22870147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2010.218
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados